Absci Corp. (ABSI)
11.07
+0.32
(+2.98%)
USD |
NASDAQ |
Oct 02, 16:00
11.10
+0.03
(+0.27%)
After-Hours: 20:00
Absci Enterprise Value : 1.702B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.702B |
| October 01, 2026 | 1.647B |
| September 30, 2026 | 1.650B |
| September 29, 2026 | 1.542B |
| September 28, 2026 | 1.431B |
| September 25, 2026 | 1.474B |
| September 24, 2026 | 1.577B |
| September 23, 2026 | 1.475B |
| September 22, 2026 | 1.640B |
| September 21, 2026 | 1.487B |
| September 18, 2026 | 1.458B |
| September 17, 2026 | 1.393B |
| September 16, 2026 | 1.182B |
| September 15, 2026 | 1.165B |
| September 14, 2026 | 1.191B |
| September 11, 2026 | 1.211B |
| September 10, 2026 | 1.216B |
| September 09, 2026 | 1.287B |
| September 08, 2026 | 1.331B |
| September 04, 2026 | 1.316B |
| September 03, 2026 | 1.312B |
| September 02, 2026 | 1.312B |
| September 01, 2026 | 1.319B |
| August 31, 2026 | 1.354B |
| August 28, 2026 | 1.297B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.419B |
| August 26, 2026 | 1.384B |
| August 25, 2026 | 1.455B |
| August 24, 2026 | 1.319B |
| August 21, 2026 | 1.441B |
| August 20, 2026 | 1.395B |
| August 19, 2026 | 1.517B |
| August 18, 2026 | 1.321B |
| August 17, 2026 | 1.388B |
| August 14, 2026 | 1.378B |
| August 13, 2026 | 1.426B |
| August 12, 2026 | 1.432B |
| August 11, 2026 | 1.417B |
| August 10, 2026 | 1.348B |
| August 07, 2026 | 1.335B |
| August 06, 2026 | 1.227B |
| August 05, 2026 | 1.244B |
| August 04, 2026 | 1.258B |
| August 03, 2026 | 1.163B |
| July 31, 2026 | 1.137B |
| July 30, 2026 | 1.113B |
| July 29, 2026 | 986.44M |
| July 28, 2026 | 1.026B |
| July 27, 2026 | 1.100B |
| July 24, 2026 | 1.100B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 11.75B |
| Prime Medicine, Inc. | 556.00M |
| Beam Therapeutics, Inc. | 1.624B |
| Moderna, Inc. | 71.96B |
| Tenax Therapeutics, Inc. | -54.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.21M |
| Revenue (Quarterly) | 0.318M |
| Total Expenses (Quarterly) | 33.53M |
| EPS Diluted (Quarterly) | -0.2109 |
| Gross Profit Margin (Quarterly) | -747.8% |
| Profit Margin (Quarterly) | -10.44K% |
| Earnings Yield | -7.23% |
| Normalized Earnings Yield | -7.444 |